MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2020 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Depreciation & Amortization (CF) came in at $3.1 million in Q4 2025, up 1.43% YoY from $3.1 million in Q4 2024, and down 1.27% on a QoQ basis from $3.2 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $3.1 million in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 1.43% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.5 million (down 2.21% YoY) and the FY2025 annual result came in at $12.5 million, down 2.23% from the prior year.
  • Depreciation & Amortization (CF) eased to $3.1 million in Q4 2025, from $3.2 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.9 million in Q4 2023 to a low of $1.8 million in Q1 2021.
  • A 5-year average of $2.8 million and a median of $3.1 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 115.71% — and 2024, when it dropped 21.5%.
  • Tracing MGTX's Depreciation & Amortization (CF) over 5 years: stood at $2.1 million in 2021, then increased by 20.85% to $2.5 million in 2022, then jumped by 56.98% to $3.9 million in 2023, then dropped by 21.5% to $3.1 million in 2024, then rose by 1.43% to $3.1 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $3.1 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 2.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.83 Mn
Dec 31, 2025 3.12 Mn
Sep 30, 2025 3.16 Mn
Jun 30, 2025 3.19 Mn
Mar 31, 2025 3.08 Mn
Dec 31, 2024 3.07 Mn
Sep 30, 2024 3.26 Mn
Jun 30, 2024 3.22 Mn
Mar 31, 2024 3.28 Mn
Dec 31, 2023 3.91 Mn
Sep 30, 2023 3.48 Mn
Jun 30, 2023 3.25 Mn
Mar 31, 2023 3.09 Mn
Dec 31, 2022 2.49 Mn
Sep 30, 2022 2.03 Mn
Jun 30, 2022 2.09 Mn
Mar 31, 2022 2.12 Mn
Dec 31, 2021 2.06 Mn
Sep 30, 2021 2.04 Mn
Jun 30, 2021 2.02 Mn